Cargando…
Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics
(See editorial commentary by Baird, on pages 621–623.) Background. Plasmodium vivax malaria commonly follows treatment of falciparum malaria in regions of co-endemicity. This is an important cause of preventable morbidity. Methods. We examined the factors contributing to the risk of recurrence of P....
Autores principales: | Douglas, Nicholas M., Nosten, François, Ashley, Elizabeth A., Phaiphun, Lucy, van Vugt, Michèle, Singhasivanon, Pratap, White, Nicholas J., Price, Ric N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060895/ https://www.ncbi.nlm.nih.gov/pubmed/21292666 http://dx.doi.org/10.1093/cid/ciq249 |
Ejemplares similares
-
Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity
por: Ashley, Elizabeth A, et al.
Publicado: (2019) -
Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
por: Douglas, Nicholas M., et al.
Publicado: (2013) -
Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial
por: Phyo, Aung Pyae, et al.
Publicado: (2011) -
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
por: Ashley, Elizabeth A., et al.
Publicado: (2010) -
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
por: Phyo, Aung Pyae, et al.
Publicado: (2016)